Compare BBCP & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBCP | CGC |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 401.0M |
| IPO Year | 2017 | 2023 |
| Metric | BBCP | CGC |
|---|---|---|
| Price | $10.53 | $0.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | 289.5K | ★ 4.2M |
| Earning Date | 06-04-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $392,867,000.00 | $12,759,000.00 |
| Revenue This Year | $4.90 | $8.27 |
| Revenue Next Year | N/A | $15.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.56 | $0.84 |
| 52 Week High | $12.19 | $2.38 |
| Indicator | BBCP | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 40.31 |
| Support Level | $10.39 | $0.84 |
| Resistance Level | $12.08 | $1.08 |
| Average True Range (ATR) | 0.49 | 0.04 |
| MACD | -0.21 | 0.00 |
| Stochastic Oscillator | 7.78 | 8.80 |
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.